tiprankstipranks
Pharmaron Beijing Schedules Financial Review Meeting
Company Announcements

Pharmaron Beijing Schedules Financial Review Meeting

Pharmaron Beijing Co., Ltd. Class H (HK:3759) has released an update.

Don't Miss our Black Friday Offers:

Pharmaron Beijing Co., Ltd. has announced a board meeting scheduled for October 29, 2024, to review and approve its financial results for the first nine months of the year. The meeting will involve the company’s board of directors, including executive and non-executive members, under the leadership of Chairman Dr. Lou Boliang. This event is significant for shareholders and potential investors as it will provide insights into the company’s financial health and future prospects.

For further insights into HK:3759 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskPharmaron Beijing’s 2024 Q3 Financial Report Unveiled
TipRanks HongKong Auto-Generated NewsdeskPharmaron Beijing Shareholders Approve Auditors
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App